IN a major step to advance cancer treatment, St. Luke's Medical Center-Quezon City (SLMC-QC) has announced its new Cancer Specialty Center that aims to deliver compassionate, all-encompassing care by ...

Quezon City launched of its new Cancer Specialty Center, a significant advancement in cancer care. This center brings ...

Consultant General, Hepatobiliary Pancreatic and Liver Transplant Surgeon at Sunway Medical Centre Velocity (SMCV), Dr Johann ...

Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years old ...

While there currently isn’t a cure for cancer, researchers are exploring several new treatments, including vaccines and gene editing, that could eventually change the face of cancer treatment.

Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug ...

Molecular and clinical determinants of targeted therapy (TT) outcomes in biliary tract cancer (BTC): Analysis of a prospectively maintained next generation sequencing (NGS) biorepository. Efficacy and ...

Patient (pt) characteristics, treatment patterns, and outcomes in unresectable hepatocellular carcinoma (uHCC) treated with first-line (1L) systemic therapy in the United States (US). Patterns of ...

AI decision support system non-homogenously influences clinical decisions in dynamic treatment regimen, as it depends on several factors including prior knowledge, preference, disease type ...

Since GPC3 can interact with growth factors such as HGF and VEGF, increased expression can contribute to the development of hepatic cancer. Another class of potential biomarkers is adhesion molecules.

“Pancreatic cancer is not a one-size-fits-all disease ... Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract In-Person Poster Session Date: January 24, 2025, 11:30 a.m. - 1 p.m ...